These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38381090)
1. RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma. Hong W; Zhang Y; Wang S; Li Z; Zheng D; Hsu S; Zhou J; Fan J; Chen Z; Xia X; Zeng Z; Gao Q; Yu M; Du S Adv Sci (Weinh); 2024 Apr; 11(16):e2308009. PubMed ID: 38381090 [TBL] [Abstract][Full Text] [Related]
2. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma. Li X; Pan YF; Chen YB; Wan QQ; Lin YK; Shang TY; Xu MY; Jiang TY; Pei MM; Tan YX; Dong LW; Wan XY Cell Death Dis; 2024 Apr; 15(4):300. PubMed ID: 38684648 [TBL] [Abstract][Full Text] [Related]
4. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC. Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis. Zhao F; Liu A; Gong X; Chen H; Wei J; Chen B; Chen S; Yang R; Fan Y; Mao R Tumori; 2022 Feb; 108(1):63-76. PubMed ID: 34165025 [TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma. Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365 [TBL] [Abstract][Full Text] [Related]
7. RNA binding protein serine/arginine splicing factor 1 promotes the proliferation, migration and invasion of hepatocellular carcinoma by interacting with RecQ protein-like 4 mRNA. Ye Y; Yu F; Li Z; Xie Y; Yu X Bioengineered; 2021 Dec; 12(1):6144-6154. PubMed ID: 34486474 [TBL] [Abstract][Full Text] [Related]
8. Disrupted BRCA1-PALB2 interaction induces tumor immunosuppression and T-lymphocyte infiltration in HCC through cGAS-STING pathway. Ma H; Kang Z; Foo TK; Shen Z; Xia B Hepatology; 2023 Jan; 77(1):33-47. PubMed ID: 35006619 [TBL] [Abstract][Full Text] [Related]
9. Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling. Shi Y; Wu Z; Liu S; Zuo D; Niu Y; Qiu Y; Qiao L; He W; Qiu J; Yuan Y; Wang G; Li B Nat Commun; 2024 Sep; 15(1):7930. PubMed ID: 39256398 [TBL] [Abstract][Full Text] [Related]
10. The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma. Thomsen MK; Skouboe MK; Boularan C; Vernejoul F; Lioux T; Leknes SL; Berthelsen MF; Riedel M; Cai H; Joseph JV; Perouzel E; Tiraby M; Vendelbo MH; Paludan SR Oncogene; 2020 Feb; 39(8):1652-1664. PubMed ID: 31740782 [TBL] [Abstract][Full Text] [Related]
11. Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy. Wang L; Bi S; Li Z; Liao A; Li Y; Yang L; Zhou X; Gao Y; Liu X; Zou Y; Zhang X; Shi J; Yu S; Yu Z; Guo J Biomaterials; 2025 Feb; 313():122766. PubMed ID: 39180916 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma. Huang Y; Sheng H; Xiao Y; Hu W; Zhang Z; Chen Y; Zhu Z; Wu D; Cao C; Sun J Radiother Oncol; 2021 Sep; 162():34-44. PubMed ID: 34214613 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity. Wang X; Hu R; Song Z; Zhao H; Pan Z; Feng Y; Yu Y; Han Q; Zhang J Cancer Lett; 2022 Oct; 547():215880. PubMed ID: 35981569 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541 [TBL] [Abstract][Full Text] [Related]
15. Enhanced NK cell activation via eEF2K-mediated potentiation of the cGAS-STING pathway in hepatocellular carcinoma. Xu Y; Sun F; Tian Y; Zeng G; Lei G; Bai Z; Wang Y; Ge X; Wang J; Xiao C; Wang Z; Hu M; Song J; Yang P; Liu R Int Immunopharmacol; 2024 Mar; 129():111628. PubMed ID: 38320351 [TBL] [Abstract][Full Text] [Related]
16. Blocking CD47 promotes antitumour immunity through CD103 Wang S; Wu Q; Chen T; Su R; Pan C; Qian J; Huang H; Yin S; Xie H; Zhou L; Zheng S J Hepatol; 2022 Aug; 77(2):467-478. PubMed ID: 35367532 [TBL] [Abstract][Full Text] [Related]
17. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345 [TBL] [Abstract][Full Text] [Related]
18. cGAS suppresses hepatocellular carcinoma independent of its cGAMP synthase activity. Ma D; Yang M; Sun C; Cui X; Xiong G; Wang Q; Jing W; Chen H; Lv X; Liu S; Li T; Zhao Y; Han L Cell Death Differ; 2024 Jun; 31(6):722-737. PubMed ID: 38594443 [TBL] [Abstract][Full Text] [Related]
19. MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling. Wang J; Zhao H; Yu J; Xu X; Jing H; Li N; Tang Y; Wang S; Li Y; Cai J; Jin J Cancer Sci; 2021 Feb; 112(2):575-588. PubMed ID: 33251678 [TBL] [Abstract][Full Text] [Related]
20. Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma. Tsai CL; Hsu FM; Tzen KY; Liu WL; Cheng AL; Cheng JC J Gastroenterol Hepatol; 2015 Aug; 30(8):1317-24. PubMed ID: 25682950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]